European Biotech Acquisition Corp.

European Biotech Acquisition Corp. (ticker: EBAC) is a blank-check company that completed its initial public offering in 2021, targeting acquisition opportunities in the European biotechnology and life sciences sector. The company filed a Form 10-Q with the SEC on August 18, 2021, reflecting its status as an active SPAC in the process of identifying a merger candidate. With a strategic focus on innovation-driven biotech businesses based in or with significant European operations, EBAC entered the market during the peak of the 2021 SPAC cycle. To access full filing history, sponsor details, and deal-status tracking for EBAC, sign up for a free account at SpacDesk.